| Literature DB >> 30072501 |
Nicholas Voutsinas1, Safet Lekperic2, Sharon Barazani2, Joseph J Titano2, Sherif I Heiba2, Edward Kim2.
Abstract
90Y radioembolization is an increasingly used treatment for both primary and metastatic malignancy in the liver. Understanding the biophysical properties, dosing concerns, and imaging appearance of this treatment is important for interventional radiologists and nuclear medicine physicians to provide important therapy. 90Y radioembolization is efficacious and safe, although the possibility of complications does exist. This article provides a comprehensive in-depth discussion about the indications for 90Y radioembolization, reviews the role of preprocedural angiography and 99mTc-macroaggregated albumin scans, illustrates different dosing techniques, compares and contrasts resin and glass microspheres, and describes potential complications.Entities:
Keywords: 90Y radioembolization; MAA; hepatocellular carcinoma; liver, cancer
Mesh:
Substances:
Year: 2018 PMID: 30072501 DOI: 10.2967/jnumed.116.186346
Source DB: PubMed Journal: J Nucl Med ISSN: 0161-5505 Impact factor: 10.057